犬细小病毒疫苗的研究进展
Progress in Vaccines against Canine Parvovirus

作者: 侯乐乐 * , 代永联 , 郝小静 :青岛市畜牧兽医研究所; 张廷荣 :青岛农业大学;

关键词: 犬细小病毒病疫苗进展Canine Parvovirus Vaccine Advance

摘要:
犬细小病毒病是一种具有高度接触性的烈性传染病,以呕吐、腹泻和白细胞减少为特征,发病率和死亡率比较高,给犬饲养业造成重大的经济损失。目前在犬细小病毒病的预防方面,以疫苗的应用最为广泛。本文概述了犬细小病毒病疫苗的研究现状,为犬细小病毒病的预防提供参考。
The canine parvovirus (CPV) disease is a deadly infection disease which characterized by acute vomiting, diarrhea, leucopenia and the high rate of incidence and mortality, and brings significantly losses to the breeding industry. Currently, prevention of CPV disease is mainly by canine parvovirus vaccines. The paper provided a review of the research and development of CPV vaccines as a reference.

文章引用: 侯乐乐 , 代永联 , 郝小静 , 张廷荣 (2013) 犬细小病毒疫苗的研究进展。 亚洲兽医病例研究, 2, 1-3. doi: 10.12677/ACRPVM.2013.21001

参考文献

[1] 祝兴林, 何剑斌, 赵玉军等. 犬细小病毒感染的研究现状[J]. 辽宁畜牧兽医, 2004, 10: 40-42.

[2] 李河林, 焦铁军, 刘淑红等. 犬细小病毒病研究进展[J]. 动物医学进展, 2008, 29(5): 73-77.

[3] 周云朵. 犬细小病毒的分离鉴定与生物学特性研究[D]. 华中农业大学, 2011.

[4] 王洪林. 犬细小病毒北京株分离和动物发病模型建立[D]. 中国农业科学院, 2009.

[5] R. V. Pollock, L. E. Carmichael. Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines. Cor- nell Veterinarian, 1982, 72(1): 16-35.

[6] S. H. Yoon, W. Jeong, H. J. Kim, et al. Molecular insights into the phylogeny of canine parvovirus 2 (CPV-2) with emphasis on Korean isolates: A Bayesian approach. Archives of Virology, 2009, 154(8): 1353-1360.

[7] 陈琛, 邬静, 张海亮等. 犬细小病毒病诊断与防治情况调查[J]. 湖北农业学, 2010, 59(8): 1926-1928.

[8] A. Pratelli, A. Cavalli, G. Normanno, et al. Immunization of pups with maternally derived antibodies to canine parvovirus (CPV) using a modified-live variant (CPV-2b). Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health, 2000, 47(4): 273-276.

[9] 夏咸柱, 叶俊华, 范泉水等. 犬细小病毒性肠炎弱毒疫苗的研究[J]. 兽医大学学报, 1989, 9(4): 325-329.

[10] R. Arnon, T. Ben-Yedidia. Old and new vaccine approaches. International Immunopharmacology, 2003, 3(8): 1195-1204.

[11] 徐进, 孙世琪, 曹随忠等. 犬细小病毒基因工程疫苗的研究进展[J]. 中国兽医科学, 2012, 42(5): 541-544.

[12] J. A. López de Turiso, E. Cortés, C. Martínez, et al. Recombi- nant vaccine for canine parvovirus in dogs. Journal of Virology, 1992, 66(5): 2748-2753.

[13] J. P. Langeveld, J. I. Casal, A. D. Osterhaus, et al. First peptide vaccine providing protection against viral infection in the target animal: Studies of canine parvovirus in dogs. Journal of Virol- ogy, 1994, 68(7): 4506-4513.

[14] 王亚君, 华育平. 犬瘟热病毒抗原表位T’TB和犬细小病毒VP2蛋白的共表达及免疫小鼠特异性抗体的测定[J]. 兽类学报, 2009, 29(2): 204-209.

[15] I. J. Amanna, M. K. Slifka. Wanted, dead or alive: New viral vaccines. Antiviral Research, 2009, 84(2): 119-130.

[16] I. Castagliuolo, R. Piccinini, E. Beggiao, et al. Mucosal genetic immunization against four adhesins protects against Staphylo- coccus aureus-induced mastitis in mice. Vaccine, 2006, 24(20): 4393-4402.

[17] C. Hatzifoti, Y. Roussel, A. G. Harris, et al. Mucosal immuniza- tion with a urease B DNA vaccine induces innate and cellular immune responses against helicobacter pylori. Helicobacter, 2006, 11(2): 113-122.

[18] R. Liu, C. Zhou, D. Wang, et al. Enhancement of DNA vaccine potency by sandwiching antigen-coding gene between secondary lymphoid tissue chemokine (SLC) and IgG Fc fragment genes. Cancer Biology & Therapy, 2006, 5(4): 427-434.

[19] W. Fuchs, J. Veits and T. C. Mettenleiter. Recombinant viruses of poultry as vector vaccines against fowl plague. Berliner und Munchener Tierarztliche Wochenschrift, 2006, 119(3-4): 160-166.

[20] W. Jiang, H. J. Baker, L. J. Swango, et al. Nucleic acid immuni- zation protects dogs against challenge with virulent canine par- vovirus. Vaccine, 1998, 16(6): 601-607.

[21] 邱薇, 范泉水, 李作生等. 犬细小病毒核酸疫苗制备及免疫试验[J]. 动物医学进展, 2006, 27(3): 78-81.

[22] 陈同海, 孙志明, 赵福广等. CPV 基因疫苗对幼貂的免疫试验[J]. 经济动物学报, 2005, 9(2): 80-83.

[23] Department of Health and Human Services. Points to consideron plasmid DNA vaccines for preventive infectious disease indica- tions. Office of the Federal Register, National Archives and Re- cords Administration, 1996, 61(250): 5-7.

[24] WHO. Technical Report Series, 1998, 878: 107.

分享
Top